Status:
COMPLETED
Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Hypertension
Eligibility:
All Genders
55+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether the relaxation response is more effective than attention control in reducing blood pressure and medication dosage in elderly adults with isolated syst...
Detailed Description
The purpose of this study is to determine whether the relaxation response is more effective than health education training (attention control) in reducing systolic blood pressure and anti-hypertensive...
Eligibility Criteria
Inclusion
- 55 years or older
- currently taking at least 2 anti-hypertensive medications
- systolic blood pressure between 140-159 mmHg
- diastolic blood pressure less than 90 mmHg
- read and understand English
- access to a telephone
- ability to attend all study visits
Exclusion
- other cardiovascular disease
- major medical illness
- previous experience with any RR eliciting technique
- current use of:beta-agonist bronchodilators, systemic corticosteroids, anti-convulsants/psychotics, immunosuppressants, cytotoxic therapy, anabolic steroids, antidepressants (other than SSRIs), dicyclomine, bile acid binding resins, or sympathomimetic medication
Key Trial Info
Start Date :
August 1 2001
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT00179543
Start Date
August 1 2001
Last Update
September 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BIDMC
Boston, Massachusetts, United States, 02215